These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 28403119)

  • 1. Combined Measurement of Soluble ST2 and Amino-Terminal Pro-B-Type Natriuretic Peptide Provides Early Assessment of Severity in Cardiogenic Shock Complicating Acute Coronary Syndrome.
    Tolppanen H; Rivas-Lasarte M; Lassus J; Sadoune M; Gayat E; Pulkki K; Arrigo M; Krastinova E; Sionis A; Parissis J; Spinar J; Januzzi J; Harjola VP; Mebazaa A;
    Crit Care Med; 2017 Jul; 45(7):e666-e673. PubMed ID: 28403119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early assessment of outcome in cardiogenic shock: relevance of plasma N-terminal pro-B-type natriuretic peptide and interleukin-6 levels.
    Jarai R; Fellner B; Haoula D; Jordanova N; Heinz G; Karth GD; Huber K; Geppert A
    Crit Care Med; 2009 Jun; 37(6):1837-44. PubMed ID: 19384228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure.
    Rudiger A; Gasser S; Fischler M; Hornemann T; von Eckardstein A; Maggiorini M
    Crit Care Med; 2006 Aug; 34(8):2140-4. PubMed ID: 16763507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of receptor for advanced glycation end products in cardiogenic shock.
    Selejan SR; Pöss J; Hewera L; Kazakov A; Böhm M; Link A
    Crit Care Med; 2012 May; 40(5):1513-22. PubMed ID: 22430238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin Measurements During Albumin Replacement in Patients With Severe Sepsis or Septic Shock.
    Masson S; Caironi P; Fanizza C; Carrer S; Caricato A; Fassini P; Vago T; Romero M; Tognoni G; Gattinoni L; Latini R;
    Crit Care Med; 2016 Apr; 44(4):707-16. PubMed ID: 26571184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Pilot Study of the Association of Amino-Terminal Pro-B-Type Natriuretic Peptide and Severity of Illness in Pediatric Septic Shock.
    Melendez E; Whitney JE; Norton JS; Silverman M; Monuteaux MC; Bachur RG
    Pediatr Crit Care Med; 2019 Feb; 20(2):e55-e60. PubMed ID: 30395024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of cardiac biomarkers to predict cardiac recovery in patients on extracorporeal membrane oxygenation support for refractory cardiogenic shock.
    Luyt CE; Landivier A; Leprince P; Bernard M; Pavie A; Chastre J; Combes A
    J Crit Care; 2012 Oct; 27(5):524.e7-14. PubMed ID: 22386227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of N-terminal pro-B-type natriuretic peptide in the prediction of outcomes in ST-elevation myocardial infarction complicated by cardiogenic shock.
    Sharma YP; Kanabar K; Santosh K; Kasinadhuni G; Krishnappa D
    Indian Heart J; 2020; 72(4):302-305. PubMed ID: 32861389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High plasma N-terminal pro-brain natriuretic peptide level found in diabetic patients after myocardial infarction is associated with an increased risk of in-hospital mortality and cardiogenic shock.
    Vergès B; Zeller M; Desgrès J; Dentan G; Laurent Y; Janin-Manificat L; L'Huillier I; Rioufol G; Beer JC; Makki H; Rochette L; Gambert P; Cottin Y
    Eur Heart J; 2005 Sep; 26(17):1734-41. PubMed ID: 15831555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NTproBNP and ST2 as predictors for all-cause and cardiovascular mortality in elderly patients with symptoms suggestive for heart failure.
    Boman K; Thormark Fröst F; Bergman AR; Olofsson M
    Biomarkers; 2018; 23(4):373-379. PubMed ID: 29355441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: an APEX AMI substudy.
    van Diepen S; Newby LK; Lopes RD; Stebbins A; Hasselblad V; James S; Roe MT; Ezekowitz JA; Moliterno DJ; Neumann FJ; Reist C; Mahaffey KW; Hochman JS; Hamm CW; Armstrong PW; Granger CB; Theroux P;
    Int J Cardiol; 2013 Oct; 168(3):2127-33. PubMed ID: 23394896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical picture and risk prediction of short-term mortality in cardiogenic shock.
    Harjola VP; Lassus J; Sionis A; Køber L; Tarvasmäki T; Spinar J; Parissis J; Banaszewski M; Silva-Cardoso J; Carubelli V; Di Somma S; Tolppanen H; Zeymer U; Thiele H; Nieminen MS; Mebazaa A; ;
    Eur J Heart Fail; 2015 May; 17(5):501-9. PubMed ID: 25820680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial Measurement of Amino-Terminal Pro-B-Type Natriuretic Peptide Predicts Adverse Cardiovascular Outcome in Children With Primary Myocardial Dysfunction and Acute Decompensated Heart Failure.
    Medar SS; Hsu DT; Ushay HM; Lamour JM; Cohen HW; Killinger JS
    Pediatr Crit Care Med; 2015 Jul; 16(6):529-34. PubMed ID: 25856472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined use of the novel biomarkers high-sensitivity troponin T and ST2 for heart failure risk stratification vs conventional assessment.
    Lupón J; de Antonio M; Galán A; Vila J; Zamora E; Urrutia A; Bayes-Genis A
    Mayo Clin Proc; 2013 Mar; 88(3):234-43. PubMed ID: 23384388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic utility of novel biomarkers of cardiovascular stress in patients with aortic stenosis undergoing valve replacement.
    Lindman BR; Breyley JG; Schilling JD; Vatterott AM; Zajarias A; Maniar HS; Damiano RJ; Moon MR; Lawton JS; Gage BF; Sintek MA; Aquino A; Holley CL; Patel NM; Lawler C; Lasala JM; Novak E
    Heart; 2015 Sep; 101(17):1382-8. PubMed ID: 26037104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 33 and ST2 in non-ST-elevation myocardial infarction: comparison with Global Registry of Acute Coronary Events Risk Scoring and NT-proBNP.
    Dhillon OS; Narayan HK; Quinn PA; Squire IB; Davies JE; Ng LL
    Am Heart J; 2011 Jun; 161(6):1163-70. PubMed ID: 21641364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of patients with cardiac amyloidosis admitted to an intensive care unit for acute heart failure.
    d'Humières T; Fard D; Damy T; Roubille F; Galat A; Doan HL; Oliver L; Dubois-Randé JL; Squara P; Lim P; Ternacle J
    Arch Cardiovasc Dis; 2018 Oct; 111(10):582-590. PubMed ID: 29709420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
    Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
    J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimarker approach with cystatin C, N-terminal pro-brain natriuretic peptide, C-reactive protein and red blood cell distribution width in risk stratification of patients with acute coronary syndromes.
    Vieira C; Nabais S; Ramos V; Braga C; Gaspar A; Azevedo P; Álvares Pereira M; Salomé N; Correia A
    Rev Port Cardiol; 2014 Mar; 33(3):127-36. PubMed ID: 24674467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent and incremental prognostic value of novel cardiac biomarkers in chronic hemodialysis patients.
    Obokata M; Sunaga H; Ishida H; Ito K; Ogawa T; Ando Y; Kurabayashi M; Negishi K
    Am Heart J; 2016 Sep; 179():29-41. PubMed ID: 27595677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.